Renewed Support for Lung Cancer Research
April 15, 2026 –The Cancer Research Society (CRS) announces the launch of the second edition of its Lung Cancer Research Grants Competition, backed by a total investment of $2 million. Building on the success of its inaugural competition, this initiative aims to accelerate scientific progress in an area where significant needs remain.
In Canada, lung cancer remains the leading cause of cancer-related deaths, while still being one of the least funded areas in research. In response to this major challenge, CRS is renewing its commitment by supporting innovative projects that enhance early detection, advance personalized treatment strategies, and improve understanding of resistance mechanisms to existing therapies.
This program will fund four translational research projects, each receiving $500,000 over 3 years. The goal is to accelerate the transition from scientific discoveries to useful, tangible applications that will benefit patients.
“Lung cancer research is essential given the significant unmet needs that remain. The success of our first edition reminds us that investing in innovative projects can pave the way for real progress. Every breakthrough matters, and through this new competition, we aim to continue driving meaningful change and offering hope to those affected and their loved ones.” – Manon Pepin, President and CEO of CRS
Thanks to our partners
CRS warmly acknowledges the exceptional generosity of its partners, Fondation Bergeron-Jetté and the Lung Health Foundation, who will each co-fund a research project. Their commitment has made this major investment possible to help outsmart lung cancer.
Call for Researchers
Funded research projects will be selected through a rigorous evaluation process conducted by an international committee of scientific experts specializing in lung cancer. Researchers interested in learning more about the application procedures are invited to visit the following page.